18 June 2013
Keywords: zeneca, reports, anticancer, successes, presented, preliminary, data
Article | 19 April 1993
Zeneca has presented preliminary data from a Phase III study of its new anti-androgen drug Casodex (formerly ICI 176334) in prostate ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.